梯瓦制药Teva Pharmaceutical Industries（TEVA）2025年第四季度及全年财报电话会议纪要「NYSE」（英文版）（20页）.pdf

1、 Corrected Transcript 1-877-FACTSET Total Pages:20 Copyright 2001-2026 FactSet CallStreet,LLC 28-Jan-2026 Teva Pharmaceutical Industries Ltd.(TEVA)Q4 2025 Earnings Call Teva Pharmaceutical Industries Ltd.(TEVA)Q4 2025 Earnings Call Corrected Transcript 28-Jan-2026 1-877-FACTSET 2 Copyright 2001-2026

2、 FactSet CallStreet,LLC CORPORATE PARTICIPANTS Christopher J.Stevo Senior Vice President-Investor Relations&Competitive Intelligence,Teva Pharmaceutical Industries Ltd.Richard Francis President,Chief Executive Officer&Director,Teva Pharmaceutical Industries Ltd.Eric A.Hughes Executive Vice President

3、-Global R&D&Chief Medical Officer,Teva Pharmaceutical Industries Ltd.Eli Kalif Executive Vice President&Chief Financial Officer,Teva Pharmaceutical Industries Ltd.OTHER PARTICIPANTS David Amsellem Analyst,Piper Sandler&Co.Louise Chen Analyst,Scotiabank Ashwani Verma Analyst,UBS Securities LLC Jason

4、M.Gerberry Analyst,BofA Securities,Inc.Chris Schott Analyst,JPMorgan Securities LLC Umer Raffat Analyst,Evercore ISI Les Sulewski Analyst,Truist Securities Dennis Ding Analyst,Jefferies LLC .MANAGEMENT DISCUSSION SECTION Operator:Hello,and welcome to the Teva Pharmaceutical Industries Limited Q4 202

5、5 Earnings Conference Call.My name is Alex.Ill be coordinating todays call.Operator Instructions Ill now hand it over to Chris Stevo,SVP,Investor Relations.Please go ahead.Christopher J.Stevo Senior Vice President-Investor Relations&Competitive Intelligence,Teva Pharmaceutical Industries Ltd.Thank y

6、ou,Alex.Good morning,and good afternoon,everyone.Thank you for joining us on our fourth quarter call.Before I turn it over to our CEO,Richard Francis,I just wanted to remind everyone that we will be making forward-looking statements on this call.Any statements we make are only as of today,and we und